Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ENFN Enfusion	$10.85 +0.5%	$10.85	$7.83 ▼ $11.80	$1.40B	0.92	735,304 shs	2.46 million shs
QTWO Q2	$73.64 -1.3%	$88.82	$63.61 ▼ $112.82	$4.60B	1.47	855,532 shs	981,794 shs
SAIC Science Applications International	$116.66 +0.4%	$110.64	$94.68 ▼ $156.34	$5.47B	0.49	675,824 shs	394,999 shs
VERX Vertex	$25.67 -6.6%	$35.35	$25.11 ▼ $60.71	$4.07B	0.7	1.52 million shs	3.06 million shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ENFN Enfusion	0.00%	0.00%	0.00%	0.00%	+34.27%
QTWO Q2	0.00%	-3.76%	-20.51%	-17.79%	+13.17%
SAIC Science Applications International	0.00%	+5.36%	+0.28%	-3.65%	-2.21%
VERX Vertex	0.00%	-20.53%	-28.38%	-33.03%	-25.85%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ENFN Enfusion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
QTWO Q2	3.188 of 5 stars	4.3	1.0	0.0	0.0	2.3	0.8	1.9
SAIC Science Applications International	2.9851 of 5 stars	2.1	0.0	2.5	0.0	2.4	1.7	2.5
VERX Vertex	4.4226 of 5 stars	4.4	4.0	0.0	0.0	2.5	4.2	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ENFN Enfusion	2.33	Hold	$12.25	12.91% Upside
QTWO Q2	2.56	Moderate Buy	$101.06	37.23% Upside
SAIC Science Applications International	2.27	Hold	$125.64	7.69% Upside
VERX Vertex	2.71	Moderate Buy	$43.69	70.21% Upside

Current Analyst Ratings Breakdown

Latest ENFN, QTWO, VERX, and SAIC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	VERX Vertex	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$42.00 ➝ $34.00
8/7/2025	VERX Vertex	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
8/7/2025	VERX Vertex	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/7/2025	VERX Vertex	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/7/2025	VERX Vertex	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$50.00 ➝ $43.00
8/7/2025	VERX Vertex	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Market Outperform ➝ Market Outperform	$61.00 ➝ $50.00
8/7/2025	VERX Vertex	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Outperform	$38.00 ➝ $30.00
8/6/2025	VERX Vertex	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$60.00 ➝ $40.00
7/31/2025	QTWO Q2	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$101.00 ➝ $102.00
7/31/2025	QTWO Q2	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$105.00 ➝ $110.00
7/31/2025	QTWO Q2	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$110.00 ➝ $115.00

(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ENFN Enfusion	$201.61M	6.94	$0.14 per share	78.75	$0.61 per share	17.79
QTWO Q2	$696.46M	6.60	$1.77 per share	41.72	$9.36 per share	7.87
SAIC Science Applications International	$7.51B	0.73	$12.36 per share	9.44	$34.29 per share	3.40
VERX Vertex	$666.78M	6.10	$0.98 per share	26.12	$1.57 per share	16.35

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ENFN Enfusion	$6.03M	$0.03	271.29	77.49	1.85	1.70%	6.67%	4.86%	N/A
QTWO Q2	-$38.54M	$0.05	1,473.09	64.60	N/A	0.66%	7.57%	3.06%	N/A
SAIC Science Applications International	$477M	$7.13	19.67	12.92	N/A	4.11%	24.18%	7.78%	9/4/2025 (Estimated)
VERX Vertex	-$52.73M	-$0.33	N/A	52.39	3.17	-7.09%	27.16%	5.11%	N/A

Latest ENFN, QTWO, VERX, and SAIC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/4/2025	N/A	SAIC Science Applications International	$2.25	N/A	N/A	N/A	$1.87 billion	N/A
8/6/2025	Q2 2025	VERX Vertex	$0.14	$0.15	+$0.01	-$0.01	$184.60 million	$184.56 million
6/2/2025	Q1	SAIC Science Applications International	$2.17	$1.92	-$0.25	N/A	$1.87 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ENFN Enfusion	N/A	N/A	N/A	N/A	N/A
QTWO Q2	N/A	N/A	N/A	N/A	N/A
SAIC Science Applications International	$1.48	1.27%	N/A	20.76%	N/A
VERX Vertex	N/A	N/A	N/A	N/A	N/A

Latest ENFN, QTWO, VERX, and SAIC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/11/2025	SAIC Science Applications International	quarterly	$0.37	1.28%	7/11/2025	7/11/2025	7/25/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ENFN Enfusion	N/A	3.62	3.62
QTWO Q2	N/A	0.90	0.90
SAIC Science Applications International	1.20	0.87	0.87
VERX Vertex	1.36	0.99	0.98

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ENFN Enfusion	81.05%
QTWO Q2	N/A
SAIC Science Applications International	76.00%
VERX Vertex	70.32%

Insider Ownership

Company	Insider Ownership
ENFN Enfusion	36.44%
QTWO Q2	0.31%
SAIC Science Applications International	0.44%
VERX Vertex	43.25%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ENFN Enfusion	890	129.00 million	81.72 million	Optionable
QTWO Q2	2,477	62.44 million	62.25 million	Optionable
SAIC Science Applications International	26,000	46.87 million	48.55 million	Optionable
VERX Vertex	1,900	158.49 million	89.94 million	Optionable

ENFN, QTWO, VERX, and SAIC Headlines

Recent News About These Companies

Vertex (NASDAQ:VERX) Lowered to "Hold" Rating by DA Davidson

1 hour ago | americanbankingnews.com

DA Davidson Downgrades Vertex (NASDAQ:VERX) to Hold

August 9 at 10:53 AM | marketbeat.com

Bank of America Issues Pessimistic Forecast for Vertex (NASDAQ:VERX) Stock Price

August 9 at 8:55 AM | marketbeat.com

What is DA Davidson's Forecast for Vertex Q3 Earnings?

August 9 at 7:49 AM | marketbeat.com

Herald Investment Management Ltd Lowers Stake in Vertex, Inc. (NASDAQ:VERX)

August 9 at 7:23 AM | marketbeat.com

Gagnon Advisors LLC Boosts Stock Position in Vertex, Inc. (NASDAQ:VERX)

August 9 at 7:14 AM | marketbeat.com

What is DA Davidson's Estimate for Vertex Q3 Earnings?

August 9 at 2:09 AM | americanbankingnews.com

Vertex (NASDAQ:VERX) Given New $43.00 Price Target at The Goldman Sachs Group

August 8 at 4:13 PM | marketbeat.com

Vertex (NASDAQ:VERX) Price Target Lowered to $50.00 at JMP Securities

August 8 at 9:56 AM | marketbeat.com

Y.D. More Investments Ltd Takes $1.44 Million Position in Vertex, Inc. (NASDAQ:VERX)

August 8 at 7:44 AM | marketbeat.com

BMO Capital Markets Has Lowered Expectations for Vertex (NASDAQ:VERX) Stock Price

August 8 at 7:08 AM | marketbeat.com

Gagnon Securities LLC Purchases 92,810 Shares of Vertex, Inc. (NASDAQ:VERX)

August 8 at 6:53 AM | marketbeat.com

Deep Dive Into Vertex Stock: Analyst Perspectives (6 Ratings)

August 8 at 2:47 AM | benzinga.com

These Analysts Slash Their Forecasts On Vertex After Q2 Results

August 8 at 2:47 AM | benzinga.com

Vertex (VERX) Hits New Low on Tempered Growth Outlook

August 8 at 2:47 AM | msn.com

Vertex (NASDAQ:VERX) Price Target Lowered to $40.00 at Needham & Company LLC

August 7 at 3:04 PM | marketbeat.com

Vertex (NASDAQ:VERX) Sets New 12-Month Low - Here's What Happened

August 7 at 12:27 PM | marketbeat.com

Vertex Inc.: Vertex Announces Second Quarter 2025 Financial Results

August 7 at 4:29 AM | finanznachrichten.de

XTX Topco Ltd Takes Position in Vertex, Inc. (NASDAQ:VERX)

August 7 at 3:38 AM | marketbeat.com

Vertex falls -23.0%

August 6, 2025 | msn.com

Vertex, Inc. (VERX) Q2 2025 Earnings Call Transcript

August 6, 2025 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ENFN, QTWO, VERX, and SAIC Company Descriptions

Enfusion NYSE:ENFN

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Q2 NYSE:QTWO

$73.64 -0.98 (-1.31%)

Closing price 08/8/2025 03:59 PM Eastern

Extended Trading

$73.66 +0.02 (+0.02%)

As of 08/8/2025 05:58 PM Eastern

Q2 Holdings, Inc. provides cloud-based digital solutions to regional and community financial institutions in the United States. The company offers Digital Banking Platform, an end-to-end digital banking platform supports its financial institution customers in their delivery of unified digital banking services across digital channels. Its digital banking platform solutions, comprising Q2 Consumer Banking, Q2 Small Business and Commercial, Q2mobile Remote Deposit Capture, Q2 Sentinel, Q2 Patrol, Q2 SMART, Q2 Contextual Personal Financial Management, Q2 Goals, Q2 CardSwap, Q2 Gro, Q2 Innovation Studio, Q2 Biller Direct, ClickSWITCH, Sensibill, Centrix Dispute Tracking System, Centrix Payments I.Q. System, and Centrix Exact/Transaction Management System. The company also provides lending solutions, which consists precisionlender solutions, a cloud-based platform, data-driven sales enablement, relationship pricing, and portfolio management solution includes precisionlender platform, premium treasury pricing, data studio, and Andi; and Q2 Cloud Lending solutions, a cloud-based digital lending platform and end-to-end lending solution that allows financial institutions, FinTechs, and Alt-FIs to automate and digitize their lending activities, supporting digital lending applications, scoring, underwriting, servicing, and collections for multiple assets classes comprising Q2 CL portal, originate, loan, marketplace, and collections. In addition, it offers Q2 Innovation Studio, an application program interface, or API, based and software development kit, or SDK, based open technology platform; and Helix, a cloud-native, real-time core processing platform. The company was formerly known as CBG Holdings, Inc. and changed its name to Q2 Holdings, Inc. in March 2013. Q2 Holdings, Inc. was founded in 2004 and is headquartered in Austin, Texas.

Science Applications International NYSE:SAIC

$116.66 +0.52 (+0.45%)

Closing price 08/8/2025 04:00 PM Eastern

Extended Trading

$116.90 +0.23 (+0.20%)

As of 08/8/2025 07:24 PM Eastern

Science Applications International Corporation provides technical, engineering, and enterprise information technology (IT) services primarily in the United States. The company's offerings include IT modernization; digital engineering; artificial intelligence; Weapon systems support design, build, modify, integrate, and sustain weapon systems; and end-to-end services, such as design, development, integration, deployment, management and operations, sustainment, and security of its customers' IT infrastructure, as well as training and simulation and ground vehicles support which integrates, modify, upgrades, and sustains ground vehicles for nation's armed forces. It serves the U.S. army and navy; air force, other Department of Defense and Federal Government; joint commands and space force; federal civilian agencies; health services; and space industries. The company was formerly known as SAIC Gemini, Inc. and changed its name to Science Applications International Corporation in September 2013. Science Applications International Corporation was founded in 1969 and is headquartered in Reston, Virginia.

Vertex NASDAQ:VERX

$25.67 -1.82 (-6.62%)

Closing price 08/8/2025 04:00 PM Eastern

Extended Trading

$25.86 +0.19 (+0.74%)

As of 08/8/2025 07:58 PM Eastern

Vertex, Inc., together with its subsidiaries, provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally. The company offers tax determination; compliance and reporting, including workflow management tools, role-based security, and event logging; tax data management; document management; analytics and insights; pre-built integration that includes mapping data fields, and business logic and configurations; industry-specific solutions; and technology specific solutions, such as chain flow accelerator and SAP-specific tools. It provides implementation services, such as configuration, data migration and implementation, and support and training; and managed services, including tax return preparation, filing and tax payment, and notice management. The company sells its software products through software licenses and software as a service subscription. Vertex, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time